Syracuse University

- manufacturer engagement in developing vaccine
- regulating organizations
- cold chain
- various production platforms

Factors involved in Manufacturing

Shin, M.D., Shukla, S., Chung, Y.H. et al. COVID-19 vaccine development and a potential nanomaterial path forward. Nat. Nanotechnol. 15, 646–655 (2020). doi: 10.1038/s41565-020-0737-y

https://doi.org/10.1038/s41565-020-0737-y

COVID-19 vaccine development and a potential
nanomaterial path forward

DCVMN, or the Developing Countries Vaccine Manufacturers Network, is a cohort of 41 multinational vaccine manufacturers in Africa, the Middle East, Latin America, and Asia involved in vaccine development from the research to supply stages. The manufacturers work to benefit both local communities as well as international consumers, and they have contributed to the efforts against coronavirus. 13 of the DCVMN organizations have an understanding of international regulations for supply, as well as vaccines with WHO-prequalified vaccine status. 

DCVMN Involvement

Regulating Organizations

The term "cold chain" refers to the maintenance of consistent temperatures for refrigerated vaccines from manufacture through delivery to health care facilities.

Learn Before

Related